WO2020163252A1
|
|
Fluid purification filters and the method of fluid purification using the same
|
US2020270573A1
|
|
Compositions and methods for improved t cells
|
WO2017214103A1
|
|
Magnetometer surgical device
|
WO2017210671A1
|
|
Methods and compositions for treating heart failure
|
WO2017205451A1
|
|
Novel functionalized n,n-dialkylamino phenyl ethers and their method of use
|
WO2017189831A1
|
|
Novel beta lactams as modulators of glutamate uptake and methods for use thereof
|
WO2017189705A1
|
|
Dll4-expressing cells and vaccine using the same
|
WO2017184558A1
|
|
Novel promysalin analogues and methods of use thereof
|
WO2017096246A1
|
|
Modulation of nad+ and nad+ metabolic pathways for treatment of disease
|
WO2017075421A1
|
|
Modification of 3' terminal ends of nucleic acids by dna polymerase theta
|
WO2017027778A1
|
|
Calcium alginate dosage formulations, and methods of making and using thereof
|
WO2017015484A1
|
|
Novel aminothiazole compounds and methods using same
|
WO2016210239A1
|
|
Methods of identifying novel antibiotics using in situ click chemistry
|
WO2016154298A1
|
|
System and method for automatic interpretation of eeg signals using a deep learning statistical model
|
MX2017009324A
|
|
Rna guided eradication of herpes simplex type i and other related herpesviruses.
|
US2018008641A1
|
|
Use of MicroRNA 375 in Augmenting Stem Cell Based and Endogenous Ischemic Tissue Repair
|
US2016367967A1
|
|
Method of regeneration of beta-cyclodextrin based adsorbent-coated silica with ozone
|